Green tea and bone metabolism.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMC 2754215)

Published in Nutr Res on July 01, 2009

Authors

Chwan-Li Shen1, James K Yeh, Jay J Cao, Jia-Sheng Wang

Author Affiliations

1: Department of Pathology, Texas Tech University Health Sciences Center, Lubbock, TX 79430-9097, USA. leslie.shen@ttuhsc.edu

Associated clinical trials:

Green Tea and Tai Chi for Bone Health (GTP-TC-Bone) | NCT00625391

Articles citing this

Green tea polyphenols supplementation and Tai Chi exercise for postmenopausal osteopenic women: safety and quality of life report. BMC Complement Altern Med (2010) 0.97

Green tea and bone health: Evidence from laboratory studies. Pharmacol Res (2011) 0.95

Green tea polyphenols attenuate deterioration of bone microarchitecture in female rats with systemic chronic inflammation. Osteoporos Int (2010) 0.92

Synergistic effects of green tea polyphenols and alphacalcidol on chronic inflammation-induced bone loss in female rats. Osteoporos Int (2010) 0.87

Effects of green tea or Sasa quelpaertensis bamboo leaves on plasma and liver lipids, erythrocyte Na efflux, and platelet aggregation in ovariectomized rats. Nutr Res Pract (2012) 0.85

Green tea polyphenols and Tai Chi for bone health: designing a placebo-controlled randomized trial. BMC Musculoskelet Disord (2009) 0.85

Green tea protects human osteoblasts from cigarette smoke-induced injury: possible clinical implication. Langenbecks Arch Surg (2011) 0.83

Association between dietary intake of flavonoid and bone mineral density in middle aged and elderly Chinese women and men. Osteoporos Int (2014) 0.82

Low-bone-mass phenotype of deficient mice for the cluster of differentiation 36 (CD36). PLoS One (2013) 0.82

Mitigation of oxidative damage by green tea polyphenols and Tai Chi exercise in postmenopausal women with osteopenia. PLoS One (2012) 0.81

Prevalence and factors associated with low bone mineral density in Saudi women: a community based survey. BMC Musculoskelet Disord (2014) 0.79

Ethanol Extracts of Fresh Davallia formosana (WL1101) Inhibit Osteoclast Differentiation by Suppressing RANKL-Induced Nuclear Factor- κ B Activation. Evid Based Complement Alternat Med (2013) 0.78

Effects of kalsis, a dietary supplement, on bone metabolism in the ovariectomized rats. J Osteoporos (2012) 0.77

Role of complementary and alternative medicine in geriatric care: A mini review. Pharmacogn Rev (2014) 0.76

Local Controlled Release of Polyphenol Conjugated with Gelatin Facilitates Bone Formation. Int J Mol Sci (2015) 0.76

Epigallocatechin-3-gallate protects against tumor necrosis factor alpha induced inhibition of osteogenesis of mesenchymal stem cells. Exp Biol Med (Maywood) (2016) 0.76

(-)-Epicatechin gallate (ECG) stimulates osteoblast differentiation via Runt-related transcription factor 2 (RUNX2) and transcriptional coactivator with PDZ-binding motif (TAZ)-mediated transcriptional activation. J Biol Chem (2014) 0.76

Different health behaviours and clinical factors associated with bone mineral density and bone turnover in premenopausal women with and without type 1 diabetes. Diabetes Metab Res Rev (2015) 0.76

Updated association of tea consumption and bone mineral density: A meta-analysis. Medicine (Baltimore) (2017) 0.75

ClC-7/Ostm1 contribute to the ability of tea polyphenols to maintain bone homeostasis in C57BL/6 mice, protecting against fluorosis. Int J Mol Med (2017) 0.75

Prevalence and Risk Factors of Osteoporosis in Women Referring to the Bone Densitometry Academic Center in Urmia, Iran. Glob J Health Sci (2015) 0.75

Application of Green Tea Catechin for Inducing the Osteogenic Differentiation of Human Dedifferentiated Fat Cells in Vitro. Int J Mol Sci (2015) 0.75

(-)-Epigallocatechin gallate but not chlorogenic acid upregulates osteoprotegerin synthesis through regulation of bone morphogenetic protein-4 in osteoblasts. Exp Ther Med (2017) 0.75

Pu-erh Tea Extract Ameliorates Ovariectomy-Induced Osteoporosis in Rats and Suppresses Osteoclastogenesis In Vitro. Front Pharmacol (2017) 0.75

Articles cited by this

(truncated to the top 100)

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell (1997) 18.91

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell (1997) 16.78

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res (2007) 14.84

Evolving concepts of rheumatoid arthritis. Nature (2003) 14.31

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A (1998) 12.61

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (1996) 11.60

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med (1999) 9.18

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature (1990) 8.94

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev (1999) 7.69

Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet (1993) 6.53

Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA (1990) 6.25

Beneficial effects of green tea--a review. J Am Coll Nutr (2006) 4.76

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74

Age and bone mass as predictors of fracture in a prospective study. J Clin Invest (1988) 4.46

Modulation of osteoclast differentiation. Endocr Rev (1992) 4.27

CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol (2004) 4.02

Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res (2009) 3.66

TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol (2001) 3.53

Transforming growth factor-beta1 to the bone. Endocr Rev (2005) 3.13

Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest (2003) 3.09

Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene (2003) 2.96

Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest (1990) 2.92

Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med (2001) 2.79

Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem (2007) 2.73

IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev (2004) 2.72

Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med (1997) 2.50

Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone (2002) 2.40

A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest (2003) 2.37

Normal bone anatomy and physiology. Clin J Am Soc Nephrol (2008) 2.29

Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab (2003) 2.27

Osteoclast-osteoblast communication. Arch Biochem Biophys (2008) 2.22

Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun (2001) 2.18

Advances in the osteoblast lineage. Biochem Cell Biol (1998) 2.15

Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res (1995) 2.12

Caspases: pharmacological manipulation of cell death. J Clin Invest (2005) 2.10

Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology (1990) 2.02

Caspases: key players in programmed cell death. Curr Opin Struct Biol (2000) 1.93

Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun (2004) 1.86

Ligand receptor interactions in the Wnt signaling pathway in Drosophila. J Biol Chem (2002) 1.84

Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today (2005) 1.84

Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr (1991) 1.83

Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res (1995) 1.79

Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology (1998) 1.75

Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum (2002) 1.72

Cells of bone: proliferation, differentiation, and hormonal regulation. Physiol Rev (1986) 1.68

Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol (1993) 1.67

Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology (2004) 1.66

Green tea: potential health benefits. Am Fam Physician (2009) 1.66

Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab (2008) 1.65

Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59

Caffeine and other predictors of bone density among pre- and perimenopausal women. Epidemiology (1993) 1.59

A new superoxide-generating oxidase in murine osteoclasts. J Biol Chem (2000) 1.50

Medicinal benefits of green tea: Part I. Review of noncancer health benefits. J Altern Complement Med (2005) 1.50

A single ascending dose study of epigallocatechin gallate in healthy volunteers. J Int Med Res (2003) 1.48

A role for TGFbeta(1) in osteoclast differentiation and survival. J Cell Sci (2000) 1.47

In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. Biochem Biophys Res Commun (1984) 1.46

Wnt regulation of chondrocyte differentiation. J Cell Sci (2002) 1.44

Oxidative stress, free radicals and bone remodeling. Clin Chem Lab Med (2008) 1.43

Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J Nutr (2003) 1.40

Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr (1998) 1.38

Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene (2004) 1.36

Tea drinking and bone mineral density in older women. Am J Clin Nutr (2000) 1.36

Osteoclast signalling pathways. Biochem Biophys Res Commun (2005) 1.36

Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol (2006) 1.35

Vitamin C supplement use and bone mineral density in postmenopausal women. J Bone Miner Res (2001) 1.31

Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol (2005) 1.31

Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts. J Periodontal Res (2004) 1.30

An essential role of cytosolic phospholipase A2alpha in prostaglandin E2-mediated bone resorption associated with inflammation. J Exp Med (2003) 1.29

Effects of tea consumption on nutrition and health. J Nutr (2000) 1.29

A duality in the roles of reactive oxygen species with respect to bone metabolism. Clin Chim Acta (2002) 1.27

Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women. Osteoporos Int (2006) 1.26

Molecular mechanisms of bone resorption by the osteoclast. Anat Rec (1989) 1.26

Recent advances in osteoclast biology and pathological bone resorption. Histol Histopathol (2004) 1.25

Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets (2007) 1.25

Coffee-associated osteoporosis offset by daily milk consumption. The Rancho Bernardo Study. JAMA (1994) 1.23

Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity. EMBO J (2003) 1.22

Integrins and signaling in osteoclast function. Matrix Biol (2000) 1.21

The health and economic consequences of osteopenia- and osteoporosis-attributable hip fractures in Germany: estimation for 2002 and projection until 2050. Osteoporos Int (2008) 1.20

Osteoporosis management: impact of fracture type on cost and quality of life in patients at risk for fracture I. Curr Med Res Opin (2008) 1.20

Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int (2007) 1.20

Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction. J Bone Miner Res (2003) 1.20

Osteoclastogenesis--current knowledge and future perspectives. J Musculoskelet Neuronal Interact (2008) 1.19

Cadmium, osteoporosis and calcium metabolism. Biometals (2004) 1.19

Signaling crosstalk between RANKL and interferons in osteoclast differentiation. Arthritis Res (2002) 1.13

Mouse osteoblasts synthesize collagenase in response to bone resorbing agents. Biochim Biophys Acta (1984) 1.13

Green tea or rosemary extract added to foods reduces nonheme-iron absorption. Am J Clin Nutr (2001) 1.13

NF-kappa B: arresting a major culprit in cancer. Drug Discov Today (2002) 1.13

The assessment of osteoporosis risk factors in Iranian women compared with Indian women. BMC Musculoskelet Disord (2008) 1.13

Green tea: biochemical and biological basis for health benefits. Vitam Horm (2001) 1.12

NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone. J Cell Biol (1994) 1.12

Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line. Osteoporos Int (2005) 1.12

Diet and lifestyle associated with increased bone mineral density: cross-sectional study of Japanese elderly women at an osteoporosis outpatient clinic. J Orthop Sci (2007) 1.10

Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology (1989) 1.09

Osteoimmunology. Int Arch Allergy Immunol (2006) 1.08

Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem Biophys Res Commun (2002) 1.07

Anti-inflammatory effect of bee venom on type II collagen-induced arthritis. Am J Chin Med (2004) 1.07

Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem Pharmacol (2001) 1.05

Tea drinking is associated with benefits on bone density in older women. Am J Clin Nutr (2007) 1.05

Habitual tea consumption and risk of osteoporosis: a prospective study in the women's health initiative observational cohort. Am J Epidemiol (2003) 1.04

Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cells. J Nutr Biochem (2006) 1.04

Articles by these authors

Serum vitamin D metabolites and intestinal calcium absorption efficiency in women. Am J Clin Nutr (2010) 2.37

Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr (2008) 2.00

Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr (2006) 1.67

Dose response to vitamin D supplementation among postmenopausal African American women. Am J Clin Nutr (2007) 1.39

Aflatoxin B1 albumin adduct levels and cellular immune status in Ghanaians. Int Immunol (2005) 1.36

Determinants of aflatoxin levels in Ghanaians: sociodemographic factors, knowledge of aflatoxin and food handling and consumption practices. Int J Hyg Environ Health (2006) 1.34

Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China. BMC Cancer (2006) 1.18

HIV and hepatocellular and esophageal carcinomas related to consumption of mycotoxin-prone foods in sub-Saharan Africa. Am J Clin Nutr (2010) 1.18

Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis (2005) 1.16

Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention. Carcinogenesis (2008) 1.15

Association between birth outcomes and aflatoxin B1 biomarker blood levels in pregnant women in Kumasi, Ghana. Trop Med Int Health (2009) 1.14

Exposure to secondhand smoke outside of a bar and a restaurant and tobacco exposure biomarkers in nonsmokers. Environ Health Perspect (2012) 1.14

Quantification of aflatoxin-B1-N7-Guanine in human urine by high-performance liquid chromatography and isotope dilution tandem mass spectrometry. Chem Res Toxicol (2006) 1.10

Reference range for serum parathyroid hormone. Endocr Pract (2006) 1.09

Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice. J Nutr (2005) 1.08

Fumonisin B1 contamination of home-grown corn in high-risk areas for esophageal and liver cancer in China. Food Addit Contam (2007) 1.08

Aflatoxin-related immune dysfunction in health and in human immunodeficiency virus disease. Clin Dev Immunol (2008) 1.07

Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract. Int J Cancer (2006) 1.05

Effects of high-protein diets on fat-free mass and muscle protein synthesis following weight loss: a randomized controlled trial. FASEB J (2013) 1.04

Vitamin d and serum cytokines in a randomized clinical trial. Int J Endocrinol (2010) 1.01

Green tea polyphenols mitigate deterioration of bone microarchitecture in middle-aged female rats. Bone (2008) 0.97

Green tea polyphenols supplementation and Tai Chi exercise for postmenopausal osteopenic women: safety and quality of life report. BMC Complement Altern Med (2010) 0.97

Protective effect of dietary long-chain n-3 polyunsaturated fatty acids on bone loss in gonad-intact middle-aged male rats. Br J Nutr (2006) 0.97

Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation-induced bone loss model. J Nutr Biochem (2009) 0.96

Green tea and bone health: Evidence from laboratory studies. Pharmacol Res (2011) 0.95

ACTH enhances chondrogenesis in multipotential progenitor cells and matrix production in chondrocytes. Bone (2004) 0.95

Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi, China. J Hepatol (2010) 0.94

Chronic toxicological evaluation of dietary NovaSil clay in Sprague-Dawley rats. Food Addit Contam (2005) 0.94

Aflatoxin and PAH exposure biomarkers in a U.S. population with a high incidence of hepatocellular carcinoma. Sci Total Environ (2010) 0.92

Comparison of the effects of Tai Chi and resistance training on bone metabolism in the elderly: a feasibility study. Am J Chin Med (2007) 0.91

Selenium in bone health: roles in antioxidant protection and cell proliferation. Nutrients (2013) 0.91

Concentrations of urinary 8-hydroxy-2'-deoxyguanosine and 8-isoprostane in women exposed to woodsmoke in a cookstove intervention study in San Marcos, Peru. Environ Int (2013) 0.88

Aflatoxin B1 modulates the expression of phenotypic markers and cytokines by splenic lymphocytes of male F344 rats. J Appl Toxicol (2013) 0.88

25-hydroxyvitamin D levels in African American and Nigerian women. Am J Hum Biol (2013) 0.87

Green tea polyphenols and Tai Chi for bone health: designing a placebo-controlled randomized trial. BMC Musculoskelet Disord (2009) 0.85

Effects of vitamin K2 on cortical and cancellous bone mass, cortical osteocyte and lacunar system, and porosity in sciatic neurectomized rats. Calcif Tissue Int (2010) 0.85

Protective actions of green tea polyphenols and alfacalcidol on bone microstructure in female rats with chronic inflammation. J Nutr Biochem (2010) 0.84

Supplementation with green tea polyphenols improves bone microstructure and quality in aged, orchidectomized rats. Calcif Tissue Int (2011) 0.84

The missense genetic polymorphisms of human CYP2A13: functional significance in carcinogen activation and identification of a null allelic variant. Toxicol Sci (2006) 0.84

Calcium and vitamin d supplementation in postmenopausal women. J Clin Endocrinol Metab (2013) 0.84

Vitamin K2 promotes bone healing in a rat femoral osteotomy model with or without glucocorticoid treatment. Calcif Tissue Int (2010) 0.83

Reduction in the urinary aflatoxin M1 biomarker as an early indicator of the efficacy of dietary interventions to reduce exposure to aflatoxins. Biomarkers (2013) 0.83

Validation of fumonisin biomarkers in F344 rats. Toxicol Appl Pharmacol (2007) 0.83

Adrenocorticotropin evokes transient elevations in intracellular free calcium ([Ca2+]i) and increases basal [Ca2+]i in resting chondrocytes through a phospholipase C-dependent mechanism. Endocrinology (2005) 0.82

4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone [corrected] induces CRM1-dependent p53 nuclear accumulation in human bronchial epithelial cells. Toxicol Sci (2010) 0.82

Comparative acute and combinative toxicity of aflatoxin B1 and T-2 toxin in animals and immortalized human cell lines. J Appl Toxicol (2006) 0.82

Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats. Calcif Tissue Int (2008) 0.82

Antibody microarray analysis of serum glycans in esophageal squamous cell carcinoma cases and controls. Proteomics Clin Appl (2009) 0.81

Thyrotoxicity of sodium arsenate, sodium perchlorate, and their mixture in zebrafish Danio rerio. Environ Sci Technol (2006) 0.81

[Analysis of trend of Oncomelania snail status in Yangtze River valley of Anhui Province, 1998-2009]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi (2011) 0.81

Occupational exposure to woodsmoke and oxidative stress in wildland firefighters. Sci Total Environ (2013) 0.81

PAH exposure in a Ghanaian population at high risk for aflatoxicosis. Sci Total Environ (2009) 0.81

Influence of growth hormone on bone marrow adipogenesis in hypophysectomized rats. Am J Physiol Endocrinol Metab (2002) 0.81

The surface-enhanced Raman spectra of aflatoxins: spectral analysis, density functional theory calculation, detection and differentiation. Analyst (2012) 0.81

Physiologically based toxicokinetics of serum aflatoxin B1-lysine adduct in F344 rats. Toxicology (2012) 0.81

Effect of vitamin K2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats. J Bone Miner Res (2003) 0.81

Mitigation of oxidative damage by green tea polyphenols and Tai Chi exercise in postmenopausal women with osteopenia. PLoS One (2012) 0.81

Green tea polyphenols benefits body composition and improves bone quality in long-term high-fat diet-induced obese rats. Nutr Res (2012) 0.81

Modulation of aflatoxin toxicity and biomarkers by lycopene in F344 rats. Toxicol Appl Pharmacol (2006) 0.80

Effects of growth hormone on bone modeling and remodeling in hypophysectomized young female rats: a bone histomorphometric study. J Bone Miner Metab (2010) 0.79

Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: a comparison with the effects of alfacalcidol. J Nutr Sci Vitaminol (Tokyo) (2006) 0.79

Tea and bone health: steps forward in translational nutrition. Am J Clin Nutr (2013) 0.79

Effects of energy deficit, dietary protein, and feeding on intracellular regulators of skeletal muscle proteolysis. FASEB J (2013) 0.79

[Impact of environmental changes on Oncomelania snail distribution in Dongting Lake beach]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi (2012) 0.79

Soy protein isolates prevent loss of bone quantity associated with obesity in rats through regulation of insulin signaling in osteoblasts. FASEB J (2013) 0.79

Complementary and alternative exercises for management of osteoarthritis. Arthritis (2011) 0.79

Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats. J Nutr Sci Vitaminol (Tokyo) (2006) 0.78

Green tea polyphenols avert chronic inflammation-induced myocardial fibrosis of female rats. Inflamm Res (2011) 0.78

Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid. Exp Anim (2006) 0.78

Effect of vitamin K2 and growth hormone on the long bones in hypophysectomized young rats: a bone histomorphometry study. J Bone Miner Metab (2007) 0.78

Toxic response indicators of microcystin-LR in F344 rats following a single-dose treatment. Toxicon (2008) 0.78

Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study. J Nutr Sci Vitaminol (Tokyo) (2006) 0.78

Green tea polyphenols improve bone microarchitecture in high-fat-diet-induced obese female rats through suppressing bone formation and erosion. J Med Food (2013) 0.78

Liquid chromatography/electrospray ionization tandem mass spectrometry analysis of octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine (HMX). Rapid Commun Mass Spectrom (2006) 0.77

Short-term supplementation of COX-2 inhibitor suppresses bone turnover in gonad-intact middle-aged male rats. J Bone Miner Metab (2006) 0.77

Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia. J Nutr Sci Vitaminol (Tokyo) (2006) 0.77

Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats. Exp Anim (2006) 0.77

Comparison of the effect of vitamin K(2) and risedronate on trabecular bone in glucocorticoid-treated rats: a bone histomorphometry study. Yonsei Med J (2009) 0.77

Calcium montmorillonite clay reduces AFB1 and FB1 biomarkers in rats exposed to single and co-exposures of aflatoxin and fumonisin. J Appl Toxicol (2013) 0.77

Vitamin K₂ prevents hyperglycemia and cancellous osteopenia in rats with streptozotocin-induced type 1 diabetes. Calcif Tissue Int (2010) 0.77

Longitudinal evaluation of aflatoxin exposure in two cohorts in south-western Uganda. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2015) 0.76

Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats. Exp Anim (2006) 0.76

Effects of alfacalcidol on cancellous and cortical bone mass in rats treated with glucocorticoid: a bone histomorphometry study. J Nutr Sci Vitaminol (Tokyo) (2007) 0.76